10 SEP 2025 · SCIENTIFIC PRESENTATION

Circular mRNA in vivo CAR-T presented at RNA World 2025

Byterna presented preclinical work on circular mRNA-based CAR-T pharmacology and its potential for in vivo immune-cell programming.

Byterna CEO Andy Xian Zeng speaking at RNA World 2025 — Andy Xian Zeng presenting at RNA World 2025, from Byterna’s official LinkedIn update.

The presentation described preclinical circular mRNA CAR-T research and the intended role of CellectLNP delivery in future in vivo immune-cell programming.